413 related articles for article (PubMed ID: 11739667)
1. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.
Stevceva L; Kelsall B; Nacsa J; Moniuszko M; Hel Z; Tryniszewska E; Franchini G
J Virol; 2002 Jan; 76(1):9-18. PubMed ID: 11739667
[TBL] [Abstract][Full Text] [Related]
2. Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques.
Stevceva L; Moniuszko M; Alvarez X; Lackner AA; Franchini G
Virology; 2004 Feb; 319(2):190-200. PubMed ID: 14980480
[TBL] [Abstract][Full Text] [Related]
3. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
4. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
[TBL] [Abstract][Full Text] [Related]
5. A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.
Hunegnaw R; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Ko EJ; Hogge CJ; Hoang T; Robert-Guroff M
Front Immunol; 2020; 11():571804. PubMed ID: 33117363
[TBL] [Abstract][Full Text] [Related]
6. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
7. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques.
Lohman BL; Miller CJ; McChesney MB
J Immunol; 1995 Dec; 155(12):5855-60. PubMed ID: 7499875
[TBL] [Abstract][Full Text] [Related]
8. Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques.
Monceaux V; Ho Tsong Fang R; Cumont MC; Hurtrel B; Estaquier J
J Virol; 2003 Sep; 77(18):10047-59. PubMed ID: 12941915
[TBL] [Abstract][Full Text] [Related]
9. SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines.
Cromwell MA; Carville A; Mansfield K; Klumpp S; Westmoreland SV; Lackner AA; Johnson RP
Am J Reprod Immunol; 2011 Mar; 65(3):242-7. PubMed ID: 21223428
[TBL] [Abstract][Full Text] [Related]
10. Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.
Ansari AA; Mayne AE; Sundstrom JB; Bostik P; Grimm B; Altman JD; Villinger F
J Virol; 2002 Feb; 76(4):1731-43. PubMed ID: 11799168
[TBL] [Abstract][Full Text] [Related]
11. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission.
Poonia B; Wang X; Veazey RS
J Reprod Immunol; 2006 Dec; 72(1-2):74-84. PubMed ID: 16956666
[TBL] [Abstract][Full Text] [Related]
12. Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques.
Abdulhaqq SA; Martinez MI; Kang G; Foulkes AS; Rodriguez IV; Nichols SM; Hunter M; Sariol CA; Ruiz LA; Ross BN; Yin X; Speicher DW; Haase AT; Marx PA; Li Q; Kraiselburd EN; Montaner LJ
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):405-13. PubMed ID: 24226059
[TBL] [Abstract][Full Text] [Related]
13. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
[TBL] [Abstract][Full Text] [Related]
14. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
[TBL] [Abstract][Full Text] [Related]
15. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.
Gordon SN; Doster MN; Kines RC; Keele BF; Brocca-Cofano E; Guan Y; Pegu P; Liyanage NP; Vaccari M; Cuburu N; Buck CB; Ferrari G; Montefiori D; Piatak M; Lifson JD; Xenophontos AM; Venzon D; Robert-Guroff M; Graham BS; Lowy DR; Schiller JT; Franchini G
J Immunol; 2014 Dec; 193(12):6172-83. PubMed ID: 25398324
[TBL] [Abstract][Full Text] [Related]
16. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
[TBL] [Abstract][Full Text] [Related]
17. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.
Spira AI; Marx PA; Patterson BK; Mahoney J; Koup RA; Wolinsky SM; Ho DD
J Exp Med; 1996 Jan; 183(1):215-25. PubMed ID: 8551225
[TBL] [Abstract][Full Text] [Related]
18. Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaques.
Abdulhaqq SA; Martinez M; Kang G; Rodriguez IV; Nichols SM; Beaumont D; Joseph J; Azzoni L; Yin X; Wise M; Weiner D; Liu Q; Foulkes A; Münch J; Kirchhoff F; Coutifaris C; Tomaras GD; Sariol C; Marx PA; Li Q; Kraiselburd EN; Montaner LJ
Nat Commun; 2019 Aug; 10(1):3753. PubMed ID: 31434895
[TBL] [Abstract][Full Text] [Related]
19. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
Sharpe SA; Cope A; Dowall S; Berry N; Ham C; Heeney JL; Hopkins D; Easterbrook L; Dennis M; Almond N; Cranage M
J Gen Virol; 2004 Sep; 85(Pt 9):2591-2602. PubMed ID: 15302953
[TBL] [Abstract][Full Text] [Related]
20. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
